drugset / Trial / NCT02305030
Effect of Opicapone at Steady State on Warfarin Pharmacokinetics
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Single-centre, open-label, fixed-sequence design consisting of 2 periods separated by a washout period of at least 14 days.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Opicapone | Small molecule | 50 mg | — |
| Subject | Warfarin | Small molecule | 25 mg | — |